Professional standards in treatment of acute inflammatory diseases of nasal cavity and paranasal sinuses for family doctors

Rhinitis is one of the most common conditions. Viruses are the main cause of inflammation of the nasal mucosa. In the development of the disease, bacterial infection joins or an opportunistic flora is activated. Therapeutic approaches include administration of antibacterial therapy if indicated (5–7 days for uncomplicated conditions, 10–14 days for complicated conditions), anti-inflammatory and mucolytic agents, non-steroidal anti-inflammatory drugs, decongestants, herbal drugs with proven anti-inflammatory effects. At the early stages, symptomatic therapy is indicated, including nasal irrigations with isotonic saline solution and both local and systemic decongestants. If there is purulent inflammation, local anti-inflammatory and antibacterial treatment can be added. One option is a silver solution. A 2% silver proteinate solution can be administered from early childhood as an antiseptic, disinfectant, and anti-inflammatory agent. The drug is effective in acute and chronic rhinitis, rhinosinusitis, and adenoiditis. Compliance with professional standards ensures effective treatment of acute inflammatory conditions of the nasal cavity and paranasal sinuses, reduces the risk of complications, and improves the quality of a patient’s life.